OTC Bulletin Board
S & P Company Insight for 3DICON CORPORATION |
| |
Profile
|
| |
| Business Summary: 3DIcon Corporation, a development stage company, focuses on developing and marketing full-color, 360-degree person-to-person holographic technology. The company also offers pixel precision, the digital micro-mirror device (DMD) control software for DMD application development markets. | | | Address 7507 S. Sandusky Ave.
Tulsa
, OK 74136-6107
Phone: 918-492-5082
Fax: 918-492-5367
Website: http://www.3dicon.net
| | Auditor |
|---|
HoganTaylor LLP
| | Transfer Agent |
|---|
Continental Stock Transfer & Trust Co.
| Employees: 4 ShareHolders: 387 | Founded: 1995 Domicile: Oklahoma | | | |
|
|
|
Background
|
| |
| 3DIcon Corporation, a development stage company, focuses on developing and marketing full-color, 360-degree person-to-person holographic technology. The company also offers pixel precision, the digital micro-mirror device (DMD) control software for DMD application development markets. It intends to serve various industries, such as retail, manufacturing, entertainment, medical, healthcare, transportation, homeland security, and the military. The company was formerly known as First Keating Corporation and changed its name to 3DIcon Corporation in August 2003. 3DIcon Corporation was incorporated in 1995 and is based in Tulsa, Oklahoma. | | History: INCORPORATED in Oklahoma Aug. 11, 1995, as First Keating Corp.; name changed to 3DIcon Corp. Oct. 31, 2003. | | | | | | | | Research and Development Expenditures, thousand. US Dollars |
|---|
| Year | Amount |
| | | | |
|
|
|
Management
|
| |
Management
|
|---|
| Officers | Position |
|---|
| Martin Keating | Chairman, Chief Financial Officer, Chief Accounting Officer & Chief Executive Officer | | James N. Welsh | President, Treasurer & Chief Operating Officer | | Hakki Refai | Chief Technology Officer | | Judith Keating nee Snider | Secretary | | Dilek Mir | Investor Relations Contact |
| | Directors |
|---|
| Martin Keating | | Victor F. Keen | | John O'Connor | | | |
|
|
|
Annual Report
|
| |
| Annual Report |
|---|
| | | Income Statement | |
| 2009 | 2008 |
|---|
| REVENUES |
|
| | License Fees | - | 25,000 | | Sales | 10,200 | 17,900 | | Grant Income | 35,139 | - | | Total Revenues | 45,339 | 42,900 | | EXPENSES |
|
| | General and Administrative | (1,218,798) | (2,578,357) | | Research and Development | (313,082) | (953,802) | | Interest | (80,294) | (122,291) | | Earnings before Taxes | (1,566,835) | (3,611,550) | | TAXES AND OTHER EXPENSES |
|
| | Net Income (Loss) | (1,566,835) | (3,611,550) | | SUPPLEMENTARY INFO |
|
| | Basic EPS - Continuing Operations | (0.01) | (0.03) |
| | | | Balance Sheet | |
| 2009 | 2008 |
|---|
| CURRENT ASSETS |
|
| | Cash | 1,118 | 48,400 | | Prepaid Expenses | 11,304 | 16,113 | | Total Current Assets | 12,422 | 64,513 | | NON CURRENT ASSETS |
|
| | Property and Equipment, net | 18,624 | 31,537 | | Debt Issue Costs-net | 16,706 | 56,978 | | Deposits and Other | 17,315 | 17,315 | | Total Assets | 65,067 | 170,343 | | CURRENT LIABILITIES |
|
| | Accounts Payable | 844,530 | 1,135,887 | | Accrued Salaries | 279,603 | 59,615 | | Accrued Interest on Debentures | 16,151 | 6,808 | | Current Maturities of Convertible Debentures Payable | 564,261 | 364,000 | | Warrant Exercise Advances | 48,511 | 140,500 | | Advance Due Officer | 11,000 | - | | Total Current Liabilities | 1,764,056 | 1,706,810 | | NON CURRENT LIABILITIES |
|
| | Convertible Debentures Payable, Less Current Maturities | 93,168 | 675,279 | | SHAREHOLDERS' EQUITY |
|
| | Common Stock - Par Value | 68,738 | 31,503 | | Additional Paid in Capital | 10,716,020 | 8,766,830 | | (Deficit)-accumulated during Development Stage | (12,576,910) | (11,010,080) | | Total Shareholders Equity | (1,792,157) | (2,211,746) | | Total Liabilities & Shareholders Equity | 65,067 | 170,343 |
| | | |
|
|
|
Interim Report
|
| |
| Interim Report
|
|---|
| | | Data Not Available | | | | | | | | | |
|
|
|
Pro Forma Report
|
| |
| Pro Forma Report
|
|---|
| | | Data Not Available | | | | | | | | | |
|
|
|
Quarterly Report
|
| |
| Quarterly Report Information
|
|---|
| | | Quarterly Revenue, US$ |
|---|
| Year | Quarter | Revenue | | 2009 |
2 | 30,000 | | 2009 |
3 | 10,000 | | 2009 |
Full Year
| 10,000 | | 2008 |
2 | 10,000 | | 2008 |
3 | 10,000 | | 2008 |
4 | 30,000 | | 2008 |
Full Year
| 40,000 | | 2007 |
2 | Nil | | 2007 |
3 | Nil | | 2007 |
Full Year
| Nil | | 2006 |
Full Year
| Nil | | 2005 |
Full Year
| Nil |
| | | | | | Quarterly Net Income, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | (320,000) | | 2009 |
1 | (500,000) | | 2009 |
2 | (310,000) | | 2009 |
3 | (370,000) | | 2009 |
4 | (380,000) | | 2009 |
Full Year
| (1,570,000) | | 2008 |
1 | (1,250,000) | | 2008 |
2 | (910,000) | | 2008 |
3 | (690,000) | | 2008 |
4 | (770,000) | | 2008 |
Full Year
| (3,610,000) | | 2007 |
2 | (810,000) | | 2007 |
3 | (780,000) | | 2007 |
4 | (1,420,000) | | 2007 |
Full Year
| (3,930,000) | | 2006 |
Full Year
| (1,470,000) | | 2005 |
Full Year
| (593,000) |
| | | | | | Quarterly EPS, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | Nil | | 2009 |
1 | Nil | | 2009 |
2 | Nil | | 2009 |
3 | Nil | | 2009 |
4 | Nil | | 2009 |
Full Year
| (.01) | | 2008 |
1 | (.01) | | 2008 |
2 | (.01) | | 2008 |
3 | Nil | | 2008 |
4 | Nil | | 2008 |
Full Year
| (.02) | | 2007 |
1 | (.01) | | 2007 |
2 | (.01) | | 2007 |
3 | (.01) | | 2007 |
4 | (.01) | | 2007 |
Full Year
| (.03) | | 2006 |
1 | Nil | | 2006 |
2 | Nil | | 2006 |
3 | Nil | | 2006 |
4 | Nil | | 2006 |
Full Year
| (.02) | | 2005 |
4 | (.01) | | 2005 |
Full Year
| (.01) |
| | | |
|
|
|
Stock Data
|
| |
| | | Capitalization as of 12/31/2009: | | | | | Authorized Shares | Outstanding Shares |
|---|
| Common $0.0002 par | 750,000,000 | 343,690,812 |
| | | | LONG TERM DEBT: $93,168. | | | | Common $0.0002 par | | | |
Stockholders:
03/31/2010,
387.
| |
Transfer Agent: Continental Stock Transfer & Trust Co.
New York
, NY | | | | OTC Bulletin Board( Primary): TDCP | | | | Exchange | Year | High | Low |
|---|
| OTC Bulletin Board | 2009 | 0.0550 | 0.0051 | | OTC Bulletin Board | 2008 | 0.3450 | 0.0400 | | OTC Bulletin Board | 2007 | 1.2000 | 0.2700 | | Over The Counter | 2006 | 3.2700 | 0.1400 | | Over The Counter | 2005 | 0.3300 | 0.0080 | | Over The Counter | 2004 | 0.6400 | 0.0300 | | Over The Counter | 2003 | 0.6000 | 0.0100 |
|
| | | | DIVIDENDS: Common $0.0002 par: No cash.
Common reverse split 1-for-10, Feb. 17, 2004. | | | | | |
|
|
|